DrugPatentWatch Database Preview
DAYTRANA Drug Profile
When do Daytrana patents expire, and when can generic versions of Daytrana launch?
Daytrana is a drug marketed by Noven Pharms Inc and is included in one NDA. There are five patents protecting this drug and one Paragraph IV challenge.
The generic ingredient in DAYTRANA is methylphenidate. There are thirty-two drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the methylphenidate profile page.
Summary for DAYTRANA
Pharmacology for DAYTRANA
| Drug Class | Central Nervous System Stimulant |
| Physiological Effect | Central Nervous System Stimulation |
Medical Subject Heading (MeSH) Categories for DAYTRANA
Synonyms for DAYTRANA
| .alpha.-Phenyl-2-piperidineacetic acid methyl ester |
| 113-45-1 |
| 2-Piperidineacetic acid, .alpha.-phenyl-, methyl ester |
| 2-Piperidineacetic acid, alpha-phenyl-, methyl ester |
| 298-59-9 (hydrochloride) |
| 4311/B Ciba |
| AB01563134_01 |
| AC1L1HJM |
| AK112570 |
| AKOS022506757 |
| alpha-Phenyl-2-piperidineacetic acid methyl ester |
| alpha-Phenyl-alpha-(2-piperidyl)acetic acid methyl ester |
| API0008866 |
| Attenta (TN) |
| BDBM50062912 |
| Biphentin (TN) |
| C 4311 |
| C07196 |
| Calocain |
| Centedein |
| Centedein (Salt/Mix) |
| Centedrin |
| Centedrin (Salt/Mix) |
| Centedrine (Salt/Mix) |
| Centredin |
| CHEBI:84276 |
| CHEMBL796 |
| Concerta |
| Concerta (TN) |
| Concerta, Methylin, Ritalin |
| Cotempla XR-ODT |
| CS-4657 |
| d-methylphenidate HCl |
| D02PPN |
| D04999 |
| Daytrana (TN) |
| DB00422 |
| DEA No. 1724 |
| DR000523 |
| DTXSID5023299 |
| DUGOZIWVEXMGBE-UHFFFAOYSA-N |
| EINECS 204-028-6 |
| Equasym (TN) |
| FT-0700534 |
| GTPL7236 |
| HE297259 |
| HSDB 3126 |
| HY-B1091 |
| L001307 |
| LS-565 |
| Meridil |
| Metadate |
| Metadate CD |
| Metadate ER |
| Metadate ER (TN) |
| Methyl .alpha.-phenyl-.alpha.-(2-piperidyl)acetate |
| Methyl .alpha.-phenyl-.alpha.-2-piperidinylacetate |
| Methyl .alpha.-phenyl-2-piperidine-acetate |
| Methyl .alpha.-phenyl-2-piperidineacetate |
| Methyl (2-phenyl-2-(2-piperidyl)acetate) |
| Methyl 2-phenyl-2-(piperidin-2-yl)acetate |
| methyl 2-phenyl-2-piperidin-2-ylacetate |
| Methyl alpha-phenyl-alpha-(2-piperidyl)acetate |
| Methyl alpha-phenyl-alpha-2-piperidinylacetate |
| methyl alpha-piperid-2-ylphenylacetate |
| Methyl phenidate |
| Methyl phenidyl acetate |
| Methyl phenidylacetate |
| Methyl phenyl(2-piperidinyl)acetate # |
| methyl phenyl(piperidin-2-yl)acetate |
| Methylfenidan |
| Methylin |
| Methylin (Salt/Mix) |
| Methylin (TN) |
| Methylin ER |
| Methylofenidan |
| Methylphen |
| Methylphenidan |
| methylphenidate |
| METHYLPHENIDATE (SEE ALSO: METHYLPHENIDATE HYDROCHLORIDE, CAS 298-59-9, NTPNO 10266-R) |
| Methylphenidate (USAN/INN) |
| Methylphenidate [INN:BAN] |
| Methylphenidate [USAN:INN:BAN] |
| Methylphenidate HCl |
| Methylphenidatum |
| Methylphenidatum [INN-Latin] |
| Methylphenidylacetate hydrochloride |
| MethyPatch |
| Metilfenidato |
| Metilfenidato [INN-Spanish] |
| Metilfenidato [Italian] |
| Motiron (TN) |
| NCGC00248587-01 |
| NCI-C56280 |
| Phenidylate |
| Plimasine |
| PMS-Methylphenidate |
| Riphenidate |
| Ritalin |
| Ritalin (Salt/Mix) |
| Ritalin (TN) |
| Ritalin LA |
| Ritalin LA (TN) |
| Ritalin SR |
| Ritalin-SR |
| Ritaline |
| Ritaline (Salt/Mix) |
| Ritcher works |
| Rubifen |
| Rubifen (TN) |
| SBI-0206868.P001 |
| SCHEMBL37178 |
| Tsentedrin |
US Patents and Regulatory Information for DAYTRANA
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Noven Pharms Inc | DAYTRANA | methylphenidate | FILM, EXTENDED RELEASE;TRANSDERMAL | 021514-001 | Apr 6, 2006 | RX | Yes | No | ➤ Try a Free Trial | ➤ Try a Free Trial | Y | ➤ Try a Free Trial | |||
| Noven Pharms Inc | DAYTRANA | methylphenidate | FILM, EXTENDED RELEASE;TRANSDERMAL | 021514-004 | Apr 6, 2006 | RX | Yes | Yes | ➤ Try a Free Trial | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Noven Pharms Inc | DAYTRANA | methylphenidate | FILM, EXTENDED RELEASE;TRANSDERMAL | 021514-002 | Apr 6, 2006 | RX | Yes | No | ➤ Try a Free Trial | ➤ Try a Free Trial | Y | ➤ Try a Free Trial | |||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Expired US Patents for DAYTRANA
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Noven Pharms Inc | DAYTRANA | methylphenidate | FILM, EXTENDED RELEASE;TRANSDERMAL | 021514-003 | Apr 6, 2006 | ➤ Try a Free Trial | ➤ Try a Free Trial |
| Noven Pharms Inc | DAYTRANA | methylphenidate | FILM, EXTENDED RELEASE;TRANSDERMAL | 021514-002 | Apr 6, 2006 | ➤ Try a Free Trial | ➤ Try a Free Trial |
| Noven Pharms Inc | DAYTRANA | methylphenidate | FILM, EXTENDED RELEASE;TRANSDERMAL | 021514-001 | Apr 6, 2006 | ➤ Try a Free Trial | ➤ Try a Free Trial |
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
Paragraph IV (Patent) Challenges for DAYTRANA
| Drugname | Dosage | Strength | RLD | Date |
|---|---|---|---|---|
| ➤ Subscribe | Transdermal System | 10 mg/9 hrs, 15 mg/9 hrs, 20 mg/9 hrs and 30 mg/9 hrs | ➤ Subscribe | ➤ Try a Free Trial |
International Patents for DAYTRANA
| Country | Document Number | Estimated Expiration |
|---|---|---|
| Norway | 329974 | ➤ Try a Free Trial |
| Colombia | 4970785 | ➤ Try a Free Trial |
| China | 101120934 | ➤ Try a Free Trial |
| Country | Document Number | Estimated Expiration |
